Literature DB >> 18095868

Synthesis and characterization of a functional intact IgG in a prokaryotic cell-free expression system.

Stephan Frey1, Martin Haslbeck, Otmar Hainzl, Johannes Buchner.   

Abstract

Antibodies are an important component of the immune system of higher eukaryotes. Furthermore, they are effective tools in basic research, medical diagnostics and therapy. Recombinant expression of these heterotetrameric, disulfide-bridged proteins is usually performed in mammalian cells. Here, we describe the cell-free expression of a mouse monoclonal antibody, MAK33, in a coupled transcription/translation system, based on an Escherichia coli lysate. Both the heavy and the light chain can be produced efficiently in this setup. However, they fail to form functional antibodies. With a view to overcome folding and oxidation defects, we supplemented the system with the oxidoreductases PDI (protein disulfide isomerase) and DsbC and the ER-specific chaperones Grp94 and BiP; furthermore, we optimized the redox conditions. We found that functional antibodies can only be obtained in the presence of an oxidoreductase. In contrast, the addition of Grp94 and/or BiP had no influence on the productive folding reaction. The comparison of the antibody expressed in vitro with MAK33 expressed in cell culture showed that the in vitro expressed antibody is correctly assembled, disulfide-bridged and shows identical antigen affinity. The stability of the in vitro expressed non-glycosylated IgG is comparable to that of the authentic antibody.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095868     DOI: 10.1515/BC.2008.007

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

2.  Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.

Authors:  Gang Yin; Eudean D Garces; Junhao Yang; Juan Zhang; Cuong Tran; Alexander R Steiner; Christine Roos; Sunil Bajad; Susan Hudak; Kalyani Penta; James Zawada; Sonia Pollitt; Christopher J Murray
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins.

Authors:  Dan Groff; Stephanie Armstrong; Patrick J Rivers; Juan Zhang; Junhao Yang; Evan Green; James Rozzelle; Shengwen Liang; Joseph D Kittle; Alexander R Steiner; Ramesh Baliga; Christopher D Thanos; Trevor J Hallam; Aaron K Sato; Alice Y Yam
Journal:  MAbs       Date:  2014-02-11       Impact factor: 5.857

4.  Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies.

Authors:  Tomohiro Makino; Georgios Skretas; Tae-Hyun Kang; George Georgiou
Journal:  Metab Eng       Date:  2010-12-03       Impact factor: 9.783

5.  Structural and functional characterization of the trifunctional antibody catumaxomab.

Authors:  Dirk Chelius; Peter Ruf; Patrick Gruber; Matthias Plöscher; Reinhard Liedtke; Eva Gansberger; Juergen Hess; Michael Wasiliu; Horst Lindhofer
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

6.  Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates.

Authors:  M Stech; O Nikolaeva; L Thoring; W F M Stöcklein; D A Wüstenhagen; M Hust; S Dübel; S Kubick
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Cell-free synthesis of functional antibody fragments to provide a structural basis for antibody-antigen interaction.

Authors:  Takayoshi Matsuda; Takuhiro Ito; Chie Takemoto; Kazushige Katsura; Mariko Ikeda; Motoaki Wakiyama; Mutsuko Kukimoto-Niino; Shigeyuki Yokoyama; Yoshikazu Kurosawa; Mikako Shirouzu
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

8.  Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system.

Authors:  Satoshi Murakami; Rena Matsumoto; Takashi Kanamori
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 9.  Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

Authors:  Md Harunur Rashid
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

10.  Development of an E. coli strain for cell-free ADC manufacturing.

Authors:  Dan Groff; Nina A Carlos; Rishard Chen; Jeffrey A Hanson; Shengwen Liang; Stephanie Armstrong; Xiaofan Li; Sihong Zhou; Alex Steiner; Trevor J Hallam; Gang Yin
Journal:  Biotechnol Bioeng       Date:  2021-10-25       Impact factor: 4.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.